Hormone therapy (HT), also known as menopausal hormone therapy, hormone replacement therapy, and estrogen replacement therapy is the most effective treatment for menopause symptoms. Conventional hormone therapy comprises of an estrogen and progesterone component that replicates hormones produced by the human ovaries. Approximately 50 million occurrences of menopause occur annually across the globe, and by 2030, there will be 1.2 billion menopausal women, thereby imposing a huge market for hormone therapy-based solutions. In the past, hormone therapy had also been recommended for those with and without menopausal symptoms to avoid osteoporosis, cognitive decline, and other common chronic conditions, but the safety and effectiveness are still under debate. Further, individual factors such as age, medical history, personal preferences, and the presence of any contraindications or risk factors are to be taken into account while making decisions about eligibility for prescribing hormone therapy.
While there are numerous benefits, there are also some associated risk factors that may differ depending on the type, dose, duration of use, route of administration, timing of initiation, and ingredients used. The prospects for hormone therapy in the future depend on the best available evidence data used to customize or personalize the course of treatment in order to maximize benefits and minimize risks, with frequent re-evaluations of the benefits and drawbacks of continuing therapy.
Our webinar will focus on these aspects of hormonal therapy:
Share your focus area or question to engage with our Analysts through the Business Objectives service.Submit My Business Objective
Our long-standing clients include some of the worlds leading brands and forward-thinking corporations.